Boyer Andrew S Insider Trades

Insider Trading History

Track insider trading activity for Boyer Andrew S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $984k 76,389 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$508k 38,195 shares
$13.30
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $5.73M 445,208 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$508k 38,195 shares
$13.30
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $5.49M 426,072 shares
Last Trade
Mar 04, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$255k 19,136 shares
$13.30
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $7.8M 606,188 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.29M 397,554 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $640k 49,695 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$661k 49,694 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $2.84M 220,788 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$323k 24,258 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $2.69M 208,634 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$162k 12,154 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $2.21M 171,733 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$265k 19,945 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $2.85M 221,427 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$661k 49,694 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $937k 72,774 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$323k 24,258 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $2.47M 191,678 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$522k 39,252 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.29M 397,554 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$522k 39,252 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $2.53M 196,530 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$331k 24,897 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $5.24M 407,013 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.65M 199,175 shares
$13.31
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $841k 65,359 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$900k 65,359 shares
$13.77
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $841k 65,359 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$900k 65,359 shares
$13.77
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $1.26M 97,480 shares
Last Trade
Aug 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65M 175,000 shares
$9.40
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $1.96M 152,426 shares
Last Trade
Aug 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.62M 279,244 shares
$9.38
$12.88
Amneal Pharmaceuticals
Amneal Pharmaceuticals AMRX
Executive Vice President
Holding Value $5.56M 431,670 shares
Last Trade
Aug 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.65M 175,000 shares
$9.40
$12.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up